Reed Jobs

Overview

Reed Jobs is the founder and managing director of Yosemite, a venture capital firm dedicated to transforming cancer from a deadly diagnosis into a manageable disease. The firm invests in oncology therapeutics, gene therapy, AI-driven drug discovery, immunotherapy, radiopharmaceuticals, and advanced biological and chemical engineering focused on cancer treatment and detection. Yosemite operates with a dual mandate of venture investing and scientific grant making, positioning itself as an early supporter of breakthroughs long before they are ready for commercial capital. Yosemite's investment strategy involves a hybrid model of grants and venture capital, allowing it to support researchers at the earliest and most fragile phase of discovery. The firm has raised more than $200 million toward its second fund, targeting a total of $350 million, with investors including Amgen, Memorial Sloan Kettering, MIT, and venture capitalist John Doerr. Reed Jobs is personally committed as a general partner in the fund. Before founding Yosemite, Reed Jobs served as the Managing Director of Health at Emerson Collective, where he built the oncology investment and philanthropy strategy. He works with a network of scientific advisers and institutional partners across biotech, cancer research, and academia. Reed serves on the Board of Directors at Conservation International, Harvard Medical School, PICI, Stanford Medicine, and Waverley Street Foundation.

Investment Focus

• Companies focused on oncology therapeutics, gene therapy, and AI-powered drug discovery

Portfolio Companies